PEGCETACOPLAN vs RAVULIZUMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
PEGCETACOPLAN vs RAVULIZUMAB: Safety Overview
| Metric | PEGCETACOPLAN | RAVULIZUMAB |
|---|---|---|
| Total FAERS Reports | 1,369 | 118 |
| Deaths Reported | 84 | 11 |
| Death Rate | 6.1% | 9.3% |
| Hospitalizations | 252 | 89 |
| Average Patient Age | 65.4 yrs | 48.4 yrs |
| % Female Patients | 70.5% | 56.3% |
| FDA Approval Date | Feb 17, 2023 | N/A |
| Manufacturer | Apellis Pharmaceuticals, Inc. | Alexion Pharmaceuticals Inc. |
| Route | SUBCUTANEOUS | INTRAVENOUS |
| Marketing Status | Prescription | N/A |